Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
drugs
3
×
fda
3
×
life sciences
national blog main
clinical trials
achaogen
adams street partners
amgen
antibiotics
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston
boston blog main
boston top stories
calcitonin gene-related peptide
chronic migraine
crispr
cystic fibrosis
cystic fibrosis foundation
deals
drug resistance
eli lilly
episodic migraine
gilead sciences
hatteras venture partners
hepatitis c
incivek
indiana
indiana blog main
indiana top stories
investing
jeff leiden
kayldeco
lyzz capital
macrolide pharmaceuticals
matt emmens
melinta therapeutics
meropenem
messenger rna therapeutics
What
medicines
3
×
drug
announced
approval
approved
bacteria
biopharma
business
cf
class
company
crisis
cystic
decision
developed
developer
disease
eli
exited
fda
fibrosis
fighting
force
headache
helped
infections
infectious
jeff
late
launches
leiden
lilly
marks
melinta
migraine
new
pain
pharmaceuticals
prevent
products
Language
unknown
Current search:
fda
×
medicines
×
drugs
×
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
